Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
90,756
-1,650
-2% -$29.4K ﹤0.01% 2889
2026
Q1
$1.76M Buy
92,406
+5,050
+6% +$97.6K ﹤0.01% 2748
2025
Q4
$1.43M Buy
87,356
+477
+0.5% +$8.4K ﹤0.01% 2819
2025
Q3
$1.63M Buy
86,879
+1,748
+2% +$31.3K ﹤0.01% 2799
2025
Q2
$1.72M Buy
85,131
+5,591
+7% +$96.6K ﹤0.01% 2717
2025
Q1
$1.09M Sell
79,540
-83,698
-51% -$1.15M ﹤0.01% 2805
2024
Q4
$1.93M Sell
163,238
-85,655
-34% -$1.35M ﹤0.01% 2690
2024
Q3
$4.47M Sell
248,893
-81,601
-25% -$1.49M ﹤0.01% 2430
2024
Q2
$5.81M Sell
330,494
-62,184
-16% -$1.28M ﹤0.01% 2292
2024
Q1
$10.1M Sell
392,678
-45,871
-10% -$1.15M ﹤0.01% 1978
2023
Q4
$11.4M Buy
438,549
+72,987
+20% +$1.67M ﹤0.01% 1915
2023
Q3
$8.43M Buy
365,562
+75,262
+26% +$1.89M ﹤0.01% 1998
2023
Q2
$6.81M Buy
290,300
+160,517
+124% +$2.72M ﹤0.01% 2087
2023
Q1
$1.54M Buy
+129,783
New +$1.85M ﹤0.01% 2594

Other funds holding XP

Charles Schwab's XP Position: Q2 2026 in Review

Charles Schwab reduced its XP (XP) stake by 1.8% in Q2 2026, selling an estimated $29.4K and leaving 90,756 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

Charles Schwab first reported a position in XP in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.4M in Q4 2023. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Charles Schwab held 90,756 shares of XP worth $1.48M as of Q2 2026.
  • Charles Schwab sold 1,650 XP shares in Q2 2026, an estimated $29.4K.
  • XP made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2889 holding.
  • Charles Schwab first reported a position in XP in Q1 2023 and has held it in 14 quarters since.
  • Charles Schwab's XP position peaked at $11.4M in Q4 2023.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.